SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006; 15: 30818.
  • 2
    Thumboo J, Wee HL. Systemic lupus erythematosus in Asia: is it more common and more severe? APLAR J Rheumatol 2006; 9: 3206.
  • 3
    Thumboo J, Uramoto K, O'Fallon WM, Fong KY, Boey ML, Feng PH, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 2001; 45: 494500.
  • 4
    Tikly M, Navarra SV. Lupus in the developing world: is it any different? Best Pract Res Clin Rheumatol 2008; 22: 64355.
  • 5
    Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006; 85: 14756.
  • 6
    Alamanos Y, Voulgari PV, Siozos C, Katsimpri P, Tsintzos S, Dimou G. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol 2003; 30: 7315.
  • 7
    Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev 2004; 3: 42353.
  • 8
    Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985; 55: 8798.
  • 9
    Chen S, Gu YY, Bao CD, Chen SL. An 18-year follow-up study of a lupus cohort in Shanghai. APLAR J Rheumatol 2006; 9: 32730.
  • 10
    Koh ET, Seow A, Leong KH, Chng HH. SLE mortality in an oriental population. Lupus 1997; 6: 2731.
  • 11
    Paton NI, Cheong I, Kong NC, Segasothy M. Mortality in Malaysians with systemic lupus erythematosus. Med J Malaysia 1996; 51: 43741.
  • 12
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 13
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 14
    Lanzon A, Navarra S. Cause of mortality among Filipino patients with systemic lupus erythematosus. Phil J Int Med 2008; 46: 15964.
  • 15
    Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005; 84: 21824.
  • 16
    Janwityanujit S, Totemchokchyakarn K, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Age-related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol 1995; 13: 1459.
  • 17
    Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994; 23: 54754.
  • 18
    Kameda S. Epidemiologic study of systemic lupus erythematosus in Fukuoka population. Fukuoka Igaku Zasshi 1988; 79: 5718.
  • 19
    Mok CC, To CH, Ho LY, Yu KL. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 2009; 35: 197882.
  • 20
    Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus 2003; 12: 32731.
  • 21
    Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 2001; 10: 43944.
  • 22
    Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust N Z J Med 1993; 23: 64651.
  • 23
    Xie SK, Feng SF, Fu H. Long term follow-up of patients with systemic lupus erythematosus. J Dermatol 1998; 25: 36773.
  • 24
    Feng JB, Ni JD, Yao X, Pan HF, Li XP, Xu JH, et al. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int 2010; 30: 101723.
  • 25
    Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 2010; 29: 3818.
  • 26
    Sung YK, Hur NW, Sinskey JL, Park D, Bae SC. Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 2007; 34: 98791.
  • 27
    Funauchi M, Shimadzu H, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, et al. Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int 2007; 27: 2439.
  • 28
    Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 2000; 9: 96100.
  • 29
    Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998; 7: 4628.
  • 30
    Zhu TY, Tam LS, Lee VW, Lee KK, Li EK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 115967.
  • 31
    Wong KL. Pattern of SLE in Hong Kong Chinese: a cohort study. Scand J Rheumatol 1992; 21: 28996.
  • 32
    To CH, Mok CC, Tang SS, Ying SK, Wong RW, Lau CS. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. Lupus 2009; 18: 126775.
  • 33
    Lee SS, Li CS, Li PC. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 1059.
  • 34
    Hoang TA, Le VK, Nguyen TV. Clinical finding and immunological testing features in patients with systemic lupus erythromatosus (SLE) treated at the Allergy & Clinical Immunology Department, Bach Mai Hospital (1996-2000). Nghien Cuu Y Hoc 2002; 17: 2735.
  • 35
    Villamin CA, Navarra SV. Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol 2008; 18: 1614.
  • 36
    Amante CM. Systemic lupus erythematosus: disease complications and therapeutic implications. Phil J Int Med 1993; 31: 2918.
  • 37
    Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2002; 20: 8591.
  • 38
    Maraina CH, Kamaliah MD, Ishak M. The autoantibody profile and its association with clinical manifestations in Malay SLE patients. Asian Pac J Allergy Immunol 2004; 22: 337.
  • 39
    Azizah MR, Ainol SS, Kong NC, Normaznah Y, Rahim MN. Demographic, clinical and immunological features of 134 Malaysian patients with systemic lupus erythematosus. Int Med J 2001; 8: 4550.
  • 40
    Yeap SS, Chow SK, Manivasagar M, Veerapen K, Wang F. Mortality patterns in Malaysian systemic lupus erythematosus patients. Med J Malaysia 2001; 56: 30812.
  • 41
    Thumboo J, Fong KY, Chng HH, Koh ET, Chia HP, Leong KH, et al. The effects of ethnicity on disease patterns in 472 Orientals with systemic lupus erythematosus. J Rheumatol 1998; 25: 1299304.
  • 42
    Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 91823.
  • 43
    Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Lupus 2007; 16: 8307.
  • 44
    Kim WU, Min JK, Lee SH, Park SH, Cho CS, Kim HY. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 1999; 17: 53945.
  • 45
    Victorio ST, Torralba TP, Katigbak BC. Survival patterns in systemic lupus erythematosus. Phil J Int Med 1988; 26: 20917.
  • 46
    Chun BC, Bae SC. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus 2005; 14: 6358.
  • 47
    Ichikawa Y, Tsunematsu T, Yokohari R, Tanimoto K, Sakane T, Yoshida H, et al. Multicenter study of causes of death in systemic lupus erythematosus: a report from the Subcommittee for Development of Therapy, the Research Committee for Autoimmune Diseases Supported by the Ministry of Health and Welfare. Ryumachi 1985; 25: 25864.
  • 48
    Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A27787.
  • 49
    Vasudevan A, Krishnamurthy AN. Changing worldwide epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 2010; 36: 113.
  • 50
    Navarra SV, King JO. An overview of clinical manifestations and survival of SLE in Asia. APLAR J Rheumatol 2006; 9: 33641.